News
Boston Scientific secured FDA approval to expand its FARAPULSE system, strengthening its grip in atrial fibrillation ...
Principal Financial Group marginally increased its stake in Marsh & McLennan Companies by 0.4%, owning $205 million worth as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback